Kinase Inhibitors
Apr 05, 2021
Kinase Inhibitors: Challenging the established Biologics as the new standard of care in autoimmune diseases?
Autoimmune and inflammatory diseases are common with a diverse array. Different organs are affected, and significant variability is seen among the individuals when talking about the severity, or the response to the treatment. Deregulated cytokine activity has a vital role in explaining autoimmune disease patho...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
